Abingdon Health Plc reported revenue results for the six months ended December 31, 2023. For the period, the company reported revenues more than doubled (+118%) to £2.4 million (first of 2022/3 £1.1 million). The growth has been driven by the company's contract service customer base across lateral flow research & development, technical transfer, manufacturing, analytical and regulatory services.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10 GBX | 0.00% | -4.76% | -9.09% |
Mar. 25 | Peel Hunt's RetailBook raises GBP2.5 million | AN |
Mar. 25 | Abingdon Health Completes Design Freeze for STD Self-Tests | MT |
1st Jan change | Capi. | |
---|---|---|
-9.09% | 38.57M | |
-0.60% | 12.63B | |
-9.59% | 7.67B | |
+1.82% | 5.42B | |
+0.02% | 4.57B | |
-51.89% | 3.51B | |
+6.42% | 2.59B | |
-14.59% | 2.05B | |
-8.29% | 1.79B | |
+1.67% | 1.77B |
- Stock Market
- Equities
- ABDX Stock
- News Abingdon Health Plc
- Abingdon Health Plc Reports Revenue Results for the Six Months Ended December 31, 2023